<DOC>
	<DOCNO>NCT00566865</DOCNO>
	<brief_summary>The primary objective study determine extent effect gemfibrozil pharmacokinetics pharmacodynamics mitiglinide .</brief_summary>
	<brief_title>Drug-Drug Interaction Study Mitiglinide Gemfibrozil</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Mitiglinide</mesh_term>
	<mesh_term>Gemfibrozil</mesh_term>
	<criteria>nonsmoker Body mass index ( BMI ) 1928 kg/m2 relevant food allergy subject gemfibrozil contraindicate subject history hypoglycemia tend get easily hypoglycemic clinically significant history current abnormality disease organ system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>